Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Biosimilars, CMOs on FDA's list for guidelines coming this year
The FDA unveiled a list of coming guidance documents that include the expected release this year of guidelines for biosimilars and quality agreements for contract manufacturing organizations.
In-Pharma Technologist (2/4)
Or we can send an email on your behalf